Relapse of HHV8-positive multicentric Castleman disease following rituximab-based therapy in HIV-positive patients-Reference-Cited by-同舟云学术

Relapse of HHV8-positive multicentric Castleman disease following rituximab-based therapy in HIV-positive patients

Published:2017-04-13 Issue:15 Volume:129 Page:2143-2147
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Pria Alessia Dalla¹,Pinato David¹,Roe Jennifer²,Naresh Kikeri³,Nelson Mark²,Bower Mark¹

Affiliation:

1. Department of Oncology, The Chelsea and Westminster Hospital, London, United Kingdom;

2. Department of HIV Medicine, The Chelsea and Westminster Hospital, London, United Kingdom; and

3. Department of Pathology, Imperial College School of Medicine, London, United Kingdom

Abstract

Key Points HIV-associated MCD remains a relapsing remitting disease despite rituximab-based therapy. Most patients can be salvaged at relapse by retreating with rituximab, but the risk of developing HHV8-associated lymphomas remains.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/129/15/2143/1399421/blood747477.pdf

Reference23 articles.

1. Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman’s disease;Soulier;Blood,1995

2. The role of immune suppression and HHV-8 in the increasing incidence of HIV-associated multicentric Castleman’s disease;Powles;Ann Oncol,2009

3. HIV-associated multicentric Castleman’s disease;Stebbing;Am J Hematol,2008

4. HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma;Dupin;Blood,2000

5. Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders;Du;Blood,2001

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human immunodeficiency virus-associated lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up;Annals of Oncology;2024-10

2. HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus;Clinical Microbiology Reviews;2024-09-12

3. Human immunodeficiency virus‐associated Lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow‐up;HemaSphere;2024-09

4. Immune deficiency/dysregulation -associated lymphoproliferative disorders. Revised classification and management;Blood Reviews;2024-03

5. Kaposi sarcoma herpesvirus/human herpesvirus 8-positive diffuse large B-cell lymphoma characterized by malignant ascites: A case report;Pathology - Research and Practice;2024-03